详情页

资源类型：

文章类型：

作者：

Enxin Wang[1] * ; Wei Bai[2] ; Zhexuan Wang[2] ; Dongdong Xia[2] ; Qiuhe Wang[2] ; Ming Huang[3] ; Junhui Sun[4] ; Wei Mu[5] ; Hui Zhao[6] ; Xingnan Pan[7] ; Guoliang Shao[8] ; Xiaoli Zhu[9] ; Guowen Yin[10] ; Haibin Shi[11] ; JianbingWu[12] ; Jiaping Li[13] ; Zhengyu Lin[14] ; Shufa Yang[15] ; Jueshi Liu[16] ; Wenhui Wang[17] ; Xu Zhu[18] ; Rong Ding[3] ; Yong Lv[1] ; Hui Chen[1] ; Kai Li[1] ; Jing Niu[1] ; Zhanxin Yin[1] ; Jielai Xia[19] ; Daiming Fan[1] ; Guohong Han[1] ;

机构： [1]National Clinical Research Center for Digestive Diseasesand Xijing Hospital of Digestive Diseases, Fourth Military MedicalUniversity, Xi’an, China [2]National Clinical Research Center for DigestiveDiseases and Xijing Hospital of Digestive Diseases, Fourth MilitaryMedical University, Xi’an, China [3]the Third Affiliated Hospital ofKunming University, Tumor Hospital of Yunnan province, Kunming,China [4]the First Affiliated Hospital, School of Medicine, ZhejiangUniversity, Hangzhou, China [5]the Southwest Hospital, Third MilitaryMedical University, Chongqing, China [6]the Affiliated Hospital ofNantong University, Nantong, China [7]Nanjing Military Command,180thHospital of PLA, Quanzhou, China [8]Zhejiang Cancer Hospital, Hangzhou,China [9]the First Affiliated Hospital of Soochow University, Suzhou,China [10]Jiangsu Provincial Cancer Hospital, the Affiliated CancerHospital of Nanjing Medical University, Nanjing, China [11]the FirstAffiliated Hospital of Nanjing Medical University, Nanjing, China [12]theSecond Affiliated Hospital of Nanchang University, Nanchang, China [13]the First Affiliated Hospital of Sun Yat-sen University, Guangzhou,China [14]First Affiliated Hospital of Fujian Medical University, Fuzhou,China [15]the Affiliated Tumor Hospital of Xinjiang Medical University,Urumqi, China [16]Hunan Provincial People’s Hospital, Changsha, China [17]the First Affiliated Hospital of Lanzhou University, Lanzhou, China [18]Peking University Cancer Hospital, Beijing, China [19]Fourth MilitaryMedical University, Xi’an, China

出处：

DOI：

ISSN：

语种：

WOS：

中科院分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区胃肠肝病学

JCR分区：

出版当年[2019]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

最新[2024]版：

Q1 GASTROENTEROLOGY & HEPATOLOGY

第一作者：

第一作者机构： [1]National Clinical Research Center for Digestive Diseasesand Xijing Hospital of Digestive Diseases, Fourth Military MedicalUniversity, Xi’an, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Identifying optimal candidates for combining transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma: A multicenter observational study

文献详情